Targeting T-cell memory: Where do we stand?

Current Opinion in Organ Transplantation

Volumn 13, Issue 4, 2008, Pages 344-349

  Valujskikh, Anna ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Costimulation; Homeostatic proliferation; Immune regulation; Lymphoablation; Memory T cells

Indexed keywords

CELLULAR IMMUNITY; HOMEOSTASIS; HUMAN; IMMUNOBIOLOGY; IMMUNOREGULATION; MEMORY T LYMPHOCYTE; NONHUMAN; ORGAN TRANSPLANTATION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; DRUG RESISTANCE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; ORGAN TRANSPLANTATION; T-LYMPHOCYTES; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 67649964633     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3283061126     Document Type: Review

References (54)

1. Bingaman AW, Farber DL. Memory T cells in transplantation: generation, function, and potential role in rejection. Am J Transplant 2004; 4:846-852.
2. Brook MO, Wood KJ, Jones ND. The impact of memory T cells on rejection and the induction of tolerance. Transplantation 2006; 82:1-9.
3. Valujskikh A. The challenge of inhibiting alloreactive T-cell memory. Am J Transplant 2006; 6:647-651.
4. Valujskikh A, Lakkis FG. In remembrance of things past: memory T cells and transplant rejection. Immunol Rev 2003; 196:65-74.
5. Valujskikh A, Li XC. Frontiers in nephrology: T cell memory as a barrier to transplant tolerance. J Am Soc Nephrol 2007; 18:2252-2261.
6. Taylor DK, Neujahr D, Turka LA. Heterologous immunity and homeostatic proliferation as barriers to tolerance. Curr Opin Immunol 2004; 16:558-564.
7. Adams AB, Williams MA, Jones TR, et al. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 2003; 111:1887-1895.
8. Chen Y, Heeger PS, Valujskikh A. In vivo helper functions of alloreactive memory CD4+ T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy. J Immunol 2004; 172:5456-5466.
9. Huehn J, Siegmund K, Lehmann JC, et al. Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J Exp Med 2004; 199:303-313.
10. Menning A, Hopken UE, Siegmund K, et al. Distinctive role of CCR7 in migration and functional activity of naive- and effector/memory-like Treg subsets. Eur J Immunol 2007; 37:1575-1583.
11. Neujahr DC, Chen C, Huang X, et al. Accelerated memory cell homeostasis during T cell depletion and approaches to overcome it. J Immunol 2006; 176:4632-4639.
12. Kroemer A, Xiao X, Vu MD, et al. OX40 controls functionally different T cell subsets and their resistance to depletion therapy. J Immunol 2007; 179:5584-5591.
13. Koyama I, Nadazdin O, Boskovic S, et al. Depletion of CD8 memory T cells for induction of tolerance of a previously transplanted kidney allograft. Am J Transplant 2007; 7:1055-1061.
14. Haanstra KG, Sick EA, Ringers J, et al. No synergy between ATG induction and costimulation blockade induced kidney allograft survival in rhesus monkeys. Transplantation 2006; 82:1194-1201.
15. Li J, Huston G, Swain SL. IL-7 promotes the transition of CD4 effectors to persistent memory cells. J Exp Med 2003; 198:1807-1815.
16. Kaech SM, Tan JT, Wherry EJ, et al. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol 2003; 4:1191-1198.
17. Goldrath AW, Sivakumar PV, Glaccum M, et al. Cytokine requirements for acute and basal homeostatic proliferation of naive and memory CD8+ T cells. J Exp Med 2002; 195:1515-1522.
18. Tan JT, Ernst B, Kieper WC, et al. Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J Exp Med 2002; 195:1523-1532.
19. Stockinger B, Bourgeois C, Kassiotis G. CD4+ memory T cells: functional differentiation and homeostasis. Immunol Rev 2006; 211:39-48.
20. Robertson JM, MacLeod M, Marsden VS, et al. Not all CD4+ memory T cells are long lived. Immunol Rev 2006; 211:49-57.
21. Surh CD, Boyman O, Purton JF, Sprent J. Homeostasis of memory T cells. Immunol Rev 2006; 211:154 - 163.
22. Arias CF, Ballesteros-Tato A, Garcia MI, et al. p21CIP1/WAF1 controls proliferation of activated/memory T cells and affects homeostasis and memory T cell responses. J Immunol 2007; 178:2296-2306.
23. Balomenos D, Martin-Caballero J, Garcia MI, et al. The cell cycle inhibitor p21 controls T-cell proliferation and sex-linked lupus development. Nat Med 2000; 6:171 -176.
24. Das L, Levine AD. TGF-beta inhibits IL-2 production and promotes cell cycle arrest in TCR-activated effector/memory T cells in the presence of sustained TCR signal transduction. J Immunol 2008; 180:1490-1498.
25. Watson AR, Lee WT. Differences in signaling molecule organization between naive and memory CD4+ T lymphocytes. J Immunol 2004; 173:33-41.
26. Chandok MR, Okoye FI, Ndejembi MP, Farber DL. A biochemical signature for rapid recall of memory CD4 T cells. J Immunol 2007; 179:3689-3698.
27. Farber DL, Luqman M, Acuto O, Bottomly K. Control of memory CD4 T cell activation: MHC class II molecules on APCs and CD4 ligation inhibit memory but not naive CD4 T cells. Immunity 1995; 2:249-259.
28. Lee WT, Vitetta ES. Memory T cells are anergic to the superantigen staphylococcal enterotoxin B. J Exp Med 1992; 176:575-579.
29. Watson AR, Lee WT. Defective T cell receptor-mediated signal transduction in memory CD4 T lymphocytes exposed to superantigen or anti-T cell receptor antibodies. Cell Immunol 2006; 242:80-90.
30. Kreuwel HT, Aung S, Silao C, Sherman LA. Memory CD8(+) T cells undergo peripheral tolerance. Immunity 2002; 17:73-81.
31. Wei CH,Trenney R, Sanchez-Alavez M, et al. Tissue-resident memory CD8+ T cells can be deleted by soluble, but not cross-presented antigen. J Immunol 2005; 175:6615-6623.
32. Verbeek R, van der Mark K, Wawrousek EF, et al. Tolerization of an established alphaB-crystallin-reactive T-cell response by intravenous antigen. Immunology 2007; 121:416-426.
33. Behrens D, Lange K, Fried A, et al. Donor-derived soluble MHC antigens plus low-dose cyclosporine induce transplantation unresponsiveness independent of the thymus by down-regulating T cell-mediated alloresponses in a rat transplantation model. Transplantation 2001; 72:1974-1982.
34. Maile R, Wang B, Schooler W, et al. Antigen-specific modulation of an immune response by in vivo administration of soluble MHC class I tetramers. J Immunol 2001; 167:3708-3714.
35. Valujskikh A, Matesic D, Heeger PS. Characterization and manipulation of T cell immunity to skin grafts expressing a transgenic minor antigen. Transplantation 1999; 68:1029-1036.
36. Dai Z, Li Q, Wang Y, et al. CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism. J Clin Invest 2004; 113:310-317.
37. Yang J, Brook MO, Carvalho-Gaspar M, et al. Allograft rejection mediated by memory T cells is resistant to regulation. Proc Natl Acad Sci USA 2007; 104:19954-19959.
38. Miller RG. An immunological suppressor cell inactivating cytotoxic T-lymphocyte precursor cells recognizing it. Nature 1 980; 287:544-546.
39. Sambhara SR, Miller RG. Programmed cell death of T cells signaled by the T cell receptor and the alpha 3 domain of class I MHC. Science 1991; 252:1424-1427.
40. Bachar-Lustig E, Reich-Zeliger S, Reisner Y. Antithird-party veto CTLs overcome rejection of hematopoietic allografts: synergism with rapamycin and BM cell dose. Blood 2003; 102:1943-1950.
41. Reich-Zeliger S, Bachar-Lustig E, Bar-Ilan A, Reisner Y. Tolerance induction in presensitized bone marrow recipients by veto CTLs: effective deletion of host antidonor memory effector cells. J Immunol 2007; 179:6389-6394.
42. Woltman AM, van der Kooij SW, de Fijter JW, van Kooten C. Maturation-resistant dendritic cells induce hyporesponsiveness in alloreactive CD45RA+ and CD45RO+ T-cell populations. Am J Transplant 2006; 6:2580-2591.
43. Borowski AB, Boesteanu AC, Mueller YM, et al. Memory CD8+T cells require CD28 costimulation. J Immunol 2007; 179:6494-6503.
44. Bennett SR, Carbone FR, Karamalis F, et al. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 1998; 393:478-480.
45. Ridge JP, Di Rosa F, Matzinger P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 1998; 393:474-478.
46. Schoenberger SP, Toes RE, van der Voort EI, et al. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 1998; 393:480-483.
47. Janssen EM, Lemmens EE, Wolfe T, et al. CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 2003; 421:852-856.
48. Shedlock DJ, Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 2003; 300:337-339.
49. Sun JC, Bevan MJ. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 2003; 300:339-342.
50. Janssen EM, Droin NM, Lemmens EE, et al. CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death. Nature 2005; 434:88-93.
51. BadovinacVP, Messingham KA, Griffith TS, HartyJT. TRAIL deficiency delays, but does not prevent, erosion in the quality of 'helpless' memory CD8 T cells. J Immunol 2006; 177:999-1006.
52. Zhai Y, Wang Y, Wu Z, Kupiec-Weglinski JW. Defective alloreactive CD8 T cell function and memory response in allograft recipients in the absence of CD4 help. J Immunol 2007; 179:4529-4534.
53. Vu MD, Clarkson MR, Yagita H, et al. Critical, but conditional, role of OX40 in memory T cell-mediated rejection. J Immunol 2006; 176:1394-1401.
54. Zhang QW, Rabant M, Schenk A, Valujskikh A. ICOS-dependent and - independent functions of memory CD4 T cells in allograft rejection. Am J Transplant 2008; 8:497-506.